DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Androgel (Testosterone Transdermal) - Published Studies

 
 



Androgel Related Published Studies

Well-designed clinical trials related to Androgel (Testosterone Transdermal)

Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. [2015]

Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. [2014]

Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial. [2014]

The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study. [2013]

Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels. [2013]

Pharmacokinetics of testosterone and estradiol gel preparations in healthy young men. [2013]

A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. [2012]

Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. [2012]

A placebo-controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effect on anthropometric, metabolic and biochemical parameters. [2011.12]

A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale. [2011.11.17]

A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men. [2011.11]

Acute testosterone deprivation reduces insulin sensitivity in men. [2011.07.29]

A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury. [2011.07]

Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. [2011.07]

Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy. [2011.07]

Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. [2011.07]

Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men. [2011.07]

Low serum testosterone levels are poor predictors of sexual dysfunction. [2011.07]

Exogenous Testosterone, Cardiovascular Events, and Cardiovascular Risk Factors in Elderly Men: A Review of Trial Data. [2011.06.15]

Structural study of prepuce in hypospadias--does topical treatment with testosterone produce alterations in prepuce vascularization? [2011.06]

Cardiovascular and cancer safety of testosterone in women. [2011.06]

The effects of circadian rhythmicity of salivary cortisol and testosterone on maximal isometric force, maximal dynamic force, and power output. [2011.06]

Changes in estradiol predict within-women shifts in attraction to facial cues of men's testosterone. [2011.06]

Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men. [2011.05]

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). [2011.04]

A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism. [2011.04]

Interaction between testosterone and growth hormone on whole-body protein anabolism occurs in the liver. [2011.04]

Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires. [2011.04]

Durability of the Effects of Testosterone and Growth Hormone Supplementation in Older Community Dwelling Men: The HORMA Trial. [2011.03.04]

Combining behavioral endocrinology and experimental economics: testosterone and social decision making. [2011.03.02]

Reduction in 24-hour plasma testosterone levels in subjects who showered 15 or 30 minutes after application of testosterone gel. [2011.03]

Effect of vitamin D supplementation on testosterone levels in men. [2011.03]

Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial. [2011.02]

Oral testosterone with and without concomitant inhibition of 5alpha-reductase by dutasteride in hypogonadal men for 28 days. [2011.02]

Testosterone is positively associated with risk taking in the Iowa Gambling Task. [2011.02]

Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? [2011.02]

Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. [2011.01]

Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trial. [2011.01]

A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men. [2011]

Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. [2011]

Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. [2011]

Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. [2010.11.16]

Testosterone therapy in women with chronic heart failure a pilot double-blind, randomized, placebo-controlled study. [2010.10.12]

Estradiol, progesterone, testosterone profiles in human follicular fluid and cultured granulosa cells from luteinized pre-ovulatory follicles. [2010.10.11]

Total Testosterone Assays in Women with Polycystic Ovary Syndrome: Precision and Correlation with Hirsutism. [2010.09.08]

Effect of endurance exercise on resting testosterone levels in sedentary subjects. [2010.09]

The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. [2010.08.27]

Hair Removal in Hirsute Women with Normal Testosterone Levels: A Randomized Controlled Trial of Long-Pulsed Diode Laser versus Intense Pulsed Light. [2010.08.20]

EFFECTS OF TESTOSTERONE SUPPLEMENTATION ON MARKERS OF THE METABOLIC SYNDROME AND INFLAMMATION IN HYPOGONADAL MEN WITH THE METABOLIC SYNDROME: THE DOUBLE-BLIND PLACEBO-CONTROLLED MOSCOW STUDY. [2010.08.13]

The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. [2010.08]

Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency. [2010.08]

A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women. [2010.07.27]

Adverse events associated with testosterone administration. [2010.07.08]

Effects of Testosterone on Skeletal Muscle Architecture in Intermediate-Frail and Frail Elderly Men. [2010.07.02]

Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. [2010.07]

Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial. [2010.07]

Testosterone decreases trust in socially naive humans. [2010.06.01]

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty. [2010.06]

Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp. [2010.06]

Validity of estimating non-sex hormone-binding globulin bound testosterone and oestradiol from total hormone measurements in boys and girls. [2010.05]

Motivational and situational factors and the relationship between testosterone dynamics and human aggression during competition. [2010.05]

Testosterone and the aging male: to treat or not to treat? [2010.05]

Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. [2010.04]

Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. [2010.04]

Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. [2010.04]

Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia. [2010.04]

Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial. [2010.03.11]

Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles. [2010.03]

A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism. [2010.02]

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. [2010.02]

Testosterone administration modulates neural responses to crying infants in young females. [2010.01]

Testosterone reduces amygdala-orbitofrontal cortex coupling. [2010.01]

Effects of testosterone administration on nocturnal cortisol secretion in healthy older men. [2010]

Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. [2010]

Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. [2010]

Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp. [2010]

Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial. [2010]

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. [2010]

Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus. [2010]

Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. [2010]

Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood. [2009.12]

Testosterone addition to estrogen therapy - effects on inflammatory markers for cardiovascular disease. [2009.12]

Effects of methyltestosterone on immunity against Salmonella Pullorum in dwarf chicks. [2009.12]

Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency. [2009.12]

The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy. [2009.12]

Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. [2009.12]

Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm. [2009.11]

Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone. [2009.11]

Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels. [2009.11]

Effects of Aromatase Inhibition on Bone Mineral Density and Bone Turnover in Older Men with Low Testosterone Levels. [2009.10.09]

Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. [2009.09.01]

Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death. [2009.09.01]

Effects of caponization and testosterone implantation on immunity in male chickens. [2009.09]

Fatty acid metabolism in the elderly: effects of dehydroepiandrosterone and testosterone replacement in hormonally deficient men and women. [2009.09]

Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents. [2009.09]

Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. [2009.09]

The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. [2009.07.20]

A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). [2009.07]

Testosterone and depression: systematic review and meta-analysis. [2009.07]

Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men. [2009.07]

Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp. [2009.07]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017